The Recall Desk
ModerateFDA (Devices)·Z-1149-2026·Announced 2026-01-28

iX series patient monitors recalled over potential cybersecurity issues

Edan Diagnostics is recalling 379 units of its Patient Monitor models iX10, iX12 and iX15 after an FDA letter raising potential cybersecurity issues with the firm's devices.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: Scored 2 because the record cites potential cybersecurity issues raised in an FDA letter, with no stated defect consequence or reported harm.

Plain-English summary

The EDAN Patient Monitor models iX10, iX12 and iX15 is being recalled by Edan Diagnostics. The record describes the product as follows: the iX series Patient Monitors, including iX10, iX12 and iX15, can perform long-time continuous monitoring of multiple physiological parameters.

The reason given in the enforcement record is that the firm received an FDA It Has Come to Our Attention Letter (IHCTOA Letter) regarding potential cybersecurity issues with various of the firm's devices.

The record lists 379 units, with model, UDI-DI and serial or lot numbers recorded in the enforcement record. Distribution was worldwide, including nationwide in the United States across a range of states listed in the record. The FDA has classified the action as Class II.

The record names no specific defect, consequence or reported harm. Facilities should follow Edan Diagnostics' instructions.

The recalled product

Product
Brand Name: EDAN Product Name: Patient Monitor Model/Catalog Number: iX10, iX12, iX15 Product Description: The iX series Patient Monitors including iX10, iX12, iX15 can perform long-time continuous monitoring of multiple physiological parameters. Also, it is capable of storing
Manufacturer
Edan Diagnostics
Hazard
  • cybersecurity
  • fda-notification

Distribution

Distributed nationwide across the United States.